Market By Education, Age Group, Drugs & Devices, End Users And Geography | Forecasts 2019-2027
The North America contraceptive market is anticipated to proliferate at a CAGR of 6.46% during the forecast period 2019-2027.
In the North American contraceptive market, the following countries have been covered:
O The United States
O Canada
The North America contraceptive market holds the maximum market share in this industry globally. The increasing adoption of contraceptives in this region can be largely attributed to the growing consciousness among the population about the importance of contraceptives. The rising cases of unplanned pregnancies, measures taken by the government to control the birth rate and the need to evade STIs. Individuals today have become largely health-conscious, and due to the increase in their disposable income, they are willing to spend on contraceptives and other preventive measures. Technological enhancements make contraceptives an effective birth control method. All these factors will go a long way in boosting the market. However, lack of awareness and misperceptions regarding the use of contraceptives have hindered the market growth. In addition, Contraceptives also bring the risk of side-effects such as breast cancer, blood clots, strokes, etc., which is an issue that requires serious consideration.
The North American market can be classified based on age group, education, drugs & devices and end users. Women in the US were provided with health insurance coverage by the government, to help them adopt contraceptives for birth control. However, due to policy changes made by the Trump government, access to these facilities has become arduous. A significant percentage of Canadian women are not able to avail the advantages of birth control due to the stagnancy of the market. Limited availability of products and lack of favorable governmental policies have proven to be a major barrier for the growth f this market.
The top contraceptive-manufacturing companies in this region are Bayer AG, Pregna, Apothecus Pharmaceutical Corporation, Teva Pharmaceutical Industries, Ltd., Pfizer, Inc., Reckitt Benckiser PLC, SMB Corporation, Afaxys, Inc., Mayer Laboratories, Inc., Melbea, Allergan, Inc., Ocon Medical, Ltd., Merck & Co., Inc., Church & Dwight Co., Inc., Okamoto Industries, Inc., Cooper Surgical, Inc. and Agile Therapeutics.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. CONTRACEPTIVE
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1.
THREAT OF NEW ENTRANTS
2.2.2.
THREAT OF SUBSTITUTE
2.2.3.
BARGAINING POWER OF BUYERS
2.2.4.
BARGAINING POWER OF SUPPLIERS
2.2.5.
THREAT OF COMPETITIVE RIVALRY
2.3. REGULATORY
OUTLOOK
2.4. PESTEL
OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. MARKET
PLAYER POSITIONING
2.7. KEY
INSIGHTS
2.7.1.
ORAL CONTRACEPTIVE ARE THE
MAJORLY USED CONTRACEPTIVE DRUGS
2.7.2.
CONDOMS ARE THE WIDELY USED
CONTRACEPTIVES DEVICE
2.7.3.
AGE GROUP OF 15–24 YEARS ARE
THE MAJOR REVENUE CONTRIBUTORS TO THE NORTH AMERICA CONTRACEPTIVE MARKET
2.8. MARKET
DRIVERS
2.8.1.
GROWING COGNIZANCE FOR
CONTRACEPTIVES
2.8.2.
INCREASING USAGE OF ORAL
CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY
2.8.3.
SURGE IN THE INITIATIVES OF
GOVERNMENT AND NGO
2.8.4.
GROWING AWARENESS ABOUT STD
2.9. MARKET
RESTRAINTS
2.9.1.
SIDE EFFECTS RESTRICTING THE
GROWTH OF CONTRACEPTIVES
2.9.2.
LIMITED ACCESS TO
CONTRACEPTIVES
2.10.
MARKET OPPORTUNITIES
2.10.1.
RISING DISPOSABLE INCOME IN
EMERGING ECONOMIES
2.10.2.
UNMET MEDICAL NEEDS IN THE
EMERGING ECONOMIES
2.10.3.
TECHNOLOGICAL ADVANCEMENTS
2.11.
MARKET CHALLENGES
2.11.1.
LACK OF ACCEPTANCE OF SOCIETY
3. CONTRACEPTIVE
MARKET OUTLOOK - BY EDUCATION
3.1. LESS
THAN HIGH SCHOOL
3.2. HIGH
SCHOOL GRADUATE
3.3. COLLEGE
GRADUATE
3.4. OTHER
COLLEGE DEGREES
4. CONTRACEPTIVE
MARKET OUTLOOK - BY AGE GROUP
4.1. 15–24
YEARS
4.2. 25–34
YEARS
4.3. 35–44
YEARS
4.4. ABOVE
44 YEARS
5. CONTRACEPTIVE
MARKET OUTLOOK - BY END USER
5.1. HOUSEHOLDS
5.2. CLINICS
5.3. HOSPITALS
6. CONTRACEPTIVE
MARKET OUTLOOK - BY DRUGS AND DEVICES
6.1. CONTRACEPTIVES
DRUGS
6.1.1.
ORAL CONTRACEPTIVE PILLS
6.1.2.
INJECTABLE CONTRACEPTIVES
6.1.3.
TOPICAL CONTRACEPTIVES
6.2. CONTRACEPTIVE
DEVICES
6.2.1.
MALE CONDOMS
6.2.2.
FEMALE CONDOMS
6.2.3.
DIAPHRAGMS
6.2.4.
CONTRACEPTIVE SPONGES
6.2.5.
VAGINAL RINGS
6.2.6.
SUBDERMAL IMPLANTS
6.2.7.
INTRA-UTERINE DEVICES
6.2.7.1. COPPER
INTRA-UTERINE DEVICES
6.2.7.2. HORMONAL
INTRA-UTERINE DEVICES
7. CONTRACEPTIVE
MARKET - REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1.
COUNTRY ANALYSIS
7.1.2. THE
UNITED STATES
7.1.3. CANADA
8. COMPETITIVE
LANDSCAPE
8.1. COMPANY
PROFILES
8.1.1.
ALLERGAN INC.
8.1.2.
BAYER AG
8.1.3.
MELBEA
8.1.4.
PREGNA
8.1.5.
PFIZER, INC.
8.1.6.
CHURCH & DWIGHT CO., INC.
8.1.7.
AFAXYS, INC.
8.1.8.
APOTHECUS PHARMACEUTICAL
CORPORATION
8.1.9.
COOPER SURGICAL INC
8.1.10.
OKAMOTO INDUSTRIES, INC
8.1.11.
MAYER LABORATORIES, INC.
8.1.12.
AGILE THERAPEUTICS
8.1.13.
MERCK & CO., INC.
8.1.14.
RECKITT BENCKISER PLC
8.1.15.
SMB CORPORATION
8.1.16.
TEVA PHARMACEUTICAL INDUSTRIES
LTD.
8.1.17.
OCON MEDICAL LTD
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 NORTH AMERICA CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
TABLE 2 CONTRACEPTIVE MARKET PLAYER POSITIONING OUTLOOK 2017
TABLE 3 NORTH AMERICA CONTRACEPTIVE MARKET BY
EDUCATION 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA CONTRACEPTIVE MARKET BY
AGE GROUP 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA CONTRACEPTIVE MARKET BY
END USER 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA CONTRACEPTIVE MARKET BY
DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA CONTRACEPTIVES DRUGS
MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA CONTRACEPTIVE DEVICES
MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA INTRA-UTERINE DEVICES
MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA CONTRACEPTIVE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 NORTH AMERICA CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 2 PORTER’S FIVE FORCE MODEL
FIGURE 3 NORTH AMERICA CONTRACEPTIVE MARKET BY LESS
THAN HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA CONTRACEPTIVE MARKET BY HIGH
SCHOOL GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA CONTRACEPTIVE MARKET BY
COLLEGE GRADUATE 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA CONTRACEPTIVE MARKET BY
OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA CONTRACEPTIVE MARKET BY
15–24 YEARS 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA CONTRACEPTIVE MARKET BY
25–34 YEARS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA CONTRACEPTIVE MARKET BY
35–44 YEARS 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA CONTRACEPTIVE MARKET BY ABOVE
44 YEARS 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA CONTRACEPTIVE MARKET BY
HOUSEHOLDS 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA CONTRACEPTIVE MARKET BY CLINICS
2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA CONTRACEPTIVE MARKET BY
HOSPITALS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA CONTRACEPTIVE MARKET BY
CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY
ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY
INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY
TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA CONTRACEPTIVE MARKET BY
CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
MALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
FEMALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY
INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 26 NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY
COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 27 NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY
HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 28 THE UNITED STATES CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 29 CANADA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)